This study assessed the subjective benefits of cochlear implants in senior patients wearing a MED-EL device. Data was compared with previous studies to assess the influence of recent speech-coding strategies and behind-the-ear speech processors; users of the behind-the-ear device and the body-worn device were also compared. An adaptation of the Nucleus 22-channel survey was sent to 141 cochlear implant users. The survey assesses perception of the device, communication benefits, handling the device and quality of life. Ninety-five surveys were returned. Results demonstrate that advanced technology provides greater benefit now than 9–13 years ago, notably: improved listening across noise, better understanding on the telephone and better speech perception. Users of the behind-the-ear device did not report more difficulties than body-worn device users but demonstrated better performance. Results show a positive outcome for cochlear implantation in a MED-EL seniors group.

Keywords:
Cochlear implant benefits, Quality of life, elderly, Speech-coding strategies
This content is only available via PDF.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.